Review
Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain

https://doi.org/10.1006/nbdi.1997.0161Get rights and content

Abstract

Age-dependent neurodegeneration in Alzheimer disease (AD) may be viewed as a complex interaction among: (i) susceptibility polymorphisms, (ii) somatic mutations or alterations that occur over extended periods of time, and (iii) environmental interactions. Putative “sporadic” diseases appear to have a much stronger genetic component than had been considered previously. For example, in Alzheimer disease, apolipoprotein E is a major susceptibility locus that accounts for approximately half the heritability. Specific APOE genotypes are associated with different relative risks and age of onset distributions. Disease may be expressed as a confluence of several genetic risk factors, superimposed upon the age-dependent increments of somatic mitochondrial mutations, and environmental determinants such as head injury, stroke, or hypoxia. A matrix involving each of these complex factors may influence the age of onset of AD in a particular individual. With careful clinically based family and epidemiological studies, it is now possible to tease out the relevant genetic contributions from the confluence of other factors leading to complex disease affecting specific sets of neurons. The highly intricate maze of contributing factors provides many potential unanticipated opportunities to design rational therapeutic and preventative strategies.

References (121)

  • M.F. Perutz

    Glutamine repeats and inherited neurodegenerative diseases: Molecular aspects

    Curr. Opin. Struct. Biol.

    (1996)
  • O. Onodera et al.

    Toxicity of expanded polyglutamine-domain proteins inEscherichia coli

    FEBS Lett.

    (1996)
  • H. Braak et al.

    The human entorhinal cortex: Normal morphology and lamina-specific pathology in various diseases

    Neurosci. Res.

    (1992)
  • B.H. Bowman et al.

    Human APOE protein localized in brains of transgenic mice

    Neurosci. Lett.

    (1996)
  • D.Y. Huang et al.

    Isoform-specific interactions of apolipoprotein E with the microtubule associated protein MAP2c: Implications for Alzheimer's disease

    Neurosci. Lett.

    (1994)
  • B.P. Nathan et al.

    The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization

    J. Biol. Chem.

    (1995)
  • M.F. Beal et al.

    Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?

    Trends Neurosci.

    (1993)
  • J.M. Shoffner et al.

    Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients

    Genomics

    (1993)
  • A.D. Roses

    A model for susceptibility polymorphisms for complex diseases: Apolipoprotein E and Alzheimer disease

    Neurogenetics

    (1997)
  • A.D. Roses et al.

    Measuring the genetic contribution of APOE in late-onset Alzheimer disease

    Am. J. Hum. Genet.

    (1995)
  • F. Schachter et al.

    Genetic associations with human longevity at the APOE and ACE loci

    Nature Genet.

    (1994)
  • J.H. Stengard et al.

    Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men

    Circulation

    (1995)
  • G. Luc et al.

    Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study

    Arterioscler. Thromb.

    (1994)
  • A.D. Roses

    Alzheimer disease as a model of molecular gerontology

    J. NIH Res.

    (1995)
  • M. Miyata et al.

    Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

    Nature Genet.

    (1996)
  • F.M. van Bockxmeer

    ApoE and ACE genes: Impact on human longevity

    Nature Genet.

    (1994)
  • A.M. Saunders et al.

    Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

    Neurology

    (1993)
  • M.I. Kamboh

    Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease

    Hum. Biol.

    (1995)
  • E.H. Corder et al.

    Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

    Science

    (1993)
  • F. Mahieux et al.

    [Isoform 4 of apolipoprotein E and Alzheimer disease. Specificity and clinical study.]

    Rev. Neurol. (Paris

    (1995)
  • G. Lucotte et al.

    Allele doses of apolipoprotein E type epsilon-4 in sporadic late-onset Alzheimer's disease

    Am. J. Med. Genet.

    (1995)
  • B.T. Hyman et al.

    Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease

    Ann. NY Acad. Sci.

    (1996)
  • A.D. Roses

    Apolipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease

    J. Neuropathol. Exp. Neurol.

    (1994)
  • E.H. Corder et al.

    Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

    Nature Genet

    (1994)
  • A.D. Roses

    Apolipoprotein E and Alzheimer's disease

    The Molecular and Genetic Basis of Neurological Disease

    (1997)
  • A.D. Roses et al.

    Alzheimer disease and other dementias

  • D. Scheuner et al.

    Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

    Nature Med.

    (1996)
  • D.J. Selkoe

    Alzheimer's disease: A central role for amyloid

    J. Neuropathol. Exp. Neurol.

    (1994)
  • D.E. Schmechel et al.

    Pattern of apolipoprotein E immunoreactivity during brain aging

  • R.I. Richards et al.

    Heritable unstable DNA sequences

    Nature Genet.

    (1992)
  • J.F. Gusella et al.

    Trinucleotide instability: A repeating theme in human inherited disorders

    Annu. Rev. Med.

    (1996)
  • A.D. Roses

    Myotonic dystrophy

  • G.W. Small et al.

    Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging

    Ann. N.Y. Acad. Sci.

    (1996)
  • E.M. Reiman et al.

    Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E

    N. Engl. J. Med.

    (1996)
  • R.A. Weeks et al.

    Positron emission tomography and central neurotransmitter systems in movement disorders

    Fundam. Clin. Pharmacol.

    (1994)
  • T. Kuwert et al.

    Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease

    J. Neurol.

    (1993)
  • G.W. Small et al.

    Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

    J. Am. Med. Assoc.

    (1995)
  • G. McKhann et al.

    Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

    Neurology

    (1984)
  • Z.S. Khachaturian

    Diagnosis of Alzheimer's disease

    Arch. Neurol.

    (1985)
  • S.S. Mirra et al.

    The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

    Neurology

    (1991)
  • Cited by (85)

    • Validation of association of the apolipoprotein e ε2 allele with neurodevelopmental dysfunction after cardiac surgery in neonates and infants

      2014, Journal of Thoracic and Cardiovascular Surgery
      Citation Excerpt :

      They speculate that APOE genotype has an intrinsic effect on the development and differentiation of functional networks in the brain. In adults, strong associations have been validated between the APOE genotype and Alzheimer disease, as well as recovery after traumatic brain injury (TBI).20,25,26 In adults, the APOE ε4 allele is associated with an increased risk of Alzheimer disease and worse recovery after TBI.

    • Spectroscopic studies of GSK3β phosphorylation of the neuronal Tau protein and its interaction with the N-terminal domain of apolipoprotein E

      2010, Journal of Biological Chemistry
      Citation Excerpt :

      However, later studies demonstrated that the central nervous system neurons also express apoE, albeit at lower levels than astrocytes (37, 68). Up-regulation of its expression level in neurons due to pathological stress, including cerebral infarction, has been reported (37, 39, 69, 70), although this protective mechanism may be overridden in individuals carrying the detrimental apoE4 allele (39, 71). Additional indirect evidence linking apoE, GSK3, and Tau comes from a recent interesting gene expression study showing that apoE and GSK3 are both differentially expressed in the entorhinal cortex where Tau pathology is thought to begin (72).

    • APOE genotype-specific differences in the innate immune response

      2009, Neurobiology of Aging
      Citation Excerpt :

      Mice that lack an APOE gene and apoE protein demonstrate a large increase in pro-inflammatory cytokines (deBont et al., 1999; Laskowitz et al., 2000) suggesting that the presence of apoE regulates macrophage function. The most prevalent variant of the APOE gene in the human population encodes the apoE3 protein, while other common variants that encode the apoE2 and apoE4 proteins are associated with disease (Mahley et al., 2006; Roses, 1997). A dose-dependent inheritance of the APOE4 allele is associated with increased risk for developing Alzheimer's disease (AD) (Corder et al., 1998; Roses, 1997) and poor outcome from neurological injury (Chapman et al., 2001; Corder et al., 1998; Grocott et al., 2001; Jordan et al., 1997; Kutner et al., 2000).

    View all citing articles on Scopus

    R. N. RosenbergS. B. PrusinerS. DiMauroR. L. Barchi, Eds.

    View full text